skip to content
Thank you for visiting First Coast Service Options' Medicare provider website. This website is intended exclusively for Medicare providers and health care industry professionals to find the latest Medicare news and information affecting the provider community.
To enable us to present you with customized content that focuses on your area of interest, please select your preferences below:
Select which best describes you:
Select your location:
Select your line of business:
This website provides information and news about the Medicare program for health care professionals only. All communication and issues regarding your Medicare benefits are handled directly by Medicare and not through this website. For the most comprehensive experience, we encourage you to visit or call 1-800-MEDICARE. In the event your provider fails to submit your Medicare claim, please view these resources for claim assistance.
Join eNews       En Español
Text Size:
YouTube LinkedIn Email Print
Send a link to this page
[Multiple email adresses must be separated by a semicolon.]

Clinical trials

Interactive LCD index

The LCD interactive index offers a fast, direct way for providers to view LCDs.
Modified: 7/16/2020
Requirements for IDEs approved by CMS.
Modified: 11/6/2022
Billing and coding instructions of routine costs for qualifying clinical trials.
Modified: 10/21/2022
Review answers to frequently-asked questions regarding clinical trials and device coverage.
Modified: 9/16/2020
Medicare covers the use of devices that are "reasonable and necessary for the diagnosis and treatment of an injury or illness or to improve the functioning of a malformed body member.”
Modified: 8/14/2020
Important information notifying users of the requirements for approval of transcatheter aortic valve replacement and transcatheter mitral valve repair (TAVR/TMVR) studies.
Modified: 7/29/2020
Medicare may provide coverage and reimbursement for certain investigational devices and services related to the use of those devices. Coverage is contingent upon meeting regulatory criteria and contractor's approval.
Modified: 7/29/2020
CAS studies are limited to FDA-approved carotid artery stents (CAS). No other post-approval studies should be submitted to First Coast Service Options for approval.
Modified: 1/20/2020
FCSO may consider coverage of a humanitarian use device, intended to benefit a small patient population, when the provider follows the specific guidelines and submits the appropriate documentation.
First Coast Service Options (First Coast) strives to ensure that the information available on our provider website is accurate, detailed, and current. Therefore, this is a dynamic site and its content changes daily. It is best to access the site to ensure you have the most current information rather than printing articles or forms that may become obsolete without notice.
Part B